Cost‐Effectiveness of Colon Cancer Screening

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The cost‐effectiveness of two colon cancer‐screening strategies was compared. The first strategy mirrors the recommendations of the American Cancer Society and includes sigmoidoscopy starting at age 50, and yearly fecal occult blood testing. The second strategy is screening with colonoscopy. The analysis revealed that the 10‐yr cost of screening with sigmoidoscopy is nearly $1,700, compared with nearly $2,500 for colonoscopy, using prevailing procedure costs. This difference can he reduced by lowering the cost of normal colonoscopies. The cost of identifying one patient with an adenomatous polyp is $8,766 with sigmoidoscopy, compared to $5,988 with colonoscopy because of the higher detection rate with colonoscopy. The calculated cost of preventing one death from colon cancer is $444,133 with sigmoidoscopy versus$347,214 with colonoscopy. In conclusion, colon cancer prevention with current screening methods is very costly. Screening with sigmoidoscopy and fecal occult blood testing may not be cost‐effective, compared to screening with colonoscopy.

Original languageEnglish (US)
Pages (from-to)1789-1794
Number of pages6
JournalAmerican Journal of Gastroenterology
Volume86
Issue number12
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Colonoscopy
Early Detection of Cancer
Colonic Neoplasms
Sigmoidoscopy
Costs and Cost Analysis
Occult Blood
Adenomatous Polyps
Colon

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Cost‐Effectiveness of Colon Cancer Screening. / Lieberman, David.

In: American Journal of Gastroenterology, Vol. 86, No. 12, 1991, p. 1789-1794.

Research output: Contribution to journalArticle

@article{211a6d0d0049449ea094a9811a5c29e4,
title = "Cost‐Effectiveness of Colon Cancer Screening",
abstract = "The cost‐effectiveness of two colon cancer‐screening strategies was compared. The first strategy mirrors the recommendations of the American Cancer Society and includes sigmoidoscopy starting at age 50, and yearly fecal occult blood testing. The second strategy is screening with colonoscopy. The analysis revealed that the 10‐yr cost of screening with sigmoidoscopy is nearly $1,700, compared with nearly $2,500 for colonoscopy, using prevailing procedure costs. This difference can he reduced by lowering the cost of normal colonoscopies. The cost of identifying one patient with an adenomatous polyp is $8,766 with sigmoidoscopy, compared to $5,988 with colonoscopy because of the higher detection rate with colonoscopy. The calculated cost of preventing one death from colon cancer is $444,133 with sigmoidoscopy versus$347,214 with colonoscopy. In conclusion, colon cancer prevention with current screening methods is very costly. Screening with sigmoidoscopy and fecal occult blood testing may not be cost‐effective, compared to screening with colonoscopy.",
author = "David Lieberman",
year = "1991",
doi = "10.1111/j.1572-0241.1991.tb06954.x",
language = "English (US)",
volume = "86",
pages = "1789--1794",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Cost‐Effectiveness of Colon Cancer Screening

AU - Lieberman, David

PY - 1991

Y1 - 1991

N2 - The cost‐effectiveness of two colon cancer‐screening strategies was compared. The first strategy mirrors the recommendations of the American Cancer Society and includes sigmoidoscopy starting at age 50, and yearly fecal occult blood testing. The second strategy is screening with colonoscopy. The analysis revealed that the 10‐yr cost of screening with sigmoidoscopy is nearly $1,700, compared with nearly $2,500 for colonoscopy, using prevailing procedure costs. This difference can he reduced by lowering the cost of normal colonoscopies. The cost of identifying one patient with an adenomatous polyp is $8,766 with sigmoidoscopy, compared to $5,988 with colonoscopy because of the higher detection rate with colonoscopy. The calculated cost of preventing one death from colon cancer is $444,133 with sigmoidoscopy versus$347,214 with colonoscopy. In conclusion, colon cancer prevention with current screening methods is very costly. Screening with sigmoidoscopy and fecal occult blood testing may not be cost‐effective, compared to screening with colonoscopy.

AB - The cost‐effectiveness of two colon cancer‐screening strategies was compared. The first strategy mirrors the recommendations of the American Cancer Society and includes sigmoidoscopy starting at age 50, and yearly fecal occult blood testing. The second strategy is screening with colonoscopy. The analysis revealed that the 10‐yr cost of screening with sigmoidoscopy is nearly $1,700, compared with nearly $2,500 for colonoscopy, using prevailing procedure costs. This difference can he reduced by lowering the cost of normal colonoscopies. The cost of identifying one patient with an adenomatous polyp is $8,766 with sigmoidoscopy, compared to $5,988 with colonoscopy because of the higher detection rate with colonoscopy. The calculated cost of preventing one death from colon cancer is $444,133 with sigmoidoscopy versus$347,214 with colonoscopy. In conclusion, colon cancer prevention with current screening methods is very costly. Screening with sigmoidoscopy and fecal occult blood testing may not be cost‐effective, compared to screening with colonoscopy.

UR - http://www.scopus.com/inward/record.url?scp=0025840366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025840366&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.1991.tb06954.x

DO - 10.1111/j.1572-0241.1991.tb06954.x

M3 - Article

C2 - 1962624

AN - SCOPUS:0025840366

VL - 86

SP - 1789

EP - 1794

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 12

ER -